Clinical Trial Results: Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ralinepag on exercise capacity in pulmonary arterial hypertension; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Ralinepag (ralinepag)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2026-07-06